<DOC>
	<DOCNO>NCT02380742</DOCNO>
	<brief_summary>The purpose study evaluate lidocaine-prilocaine ( EMLA 5 % ) cream reduce pain discomfort time vaginal pessary removal insertion . Half participant receive lidocaine-prilocaine ( EMLA 5 % ) cream half receive placebo cream .</brief_summary>
	<brief_title>Topical Anesthetic Use In Pessary Management</brief_title>
	<detailed_description>Lidocaine-prilocaine ( EMLA 5 % ) cream show effective reduce pain minor gynecologic procedure . The primary objective trial determine use 5 % EMLA cream time pessary removal insertion reduces pain compare use placebo cream . Participants randomize receive either 10 gram 5 % EMLA cream ( 4 mL ) 4 mL placebo cream ( aqueous cream BP ) . Cream apply office time pessary removal insertion .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Women Loyola Urogynecology clinic use pessary management pelvic organ prolapse ( POP ) urinary incontinence ( UI ) Read speak English language NonEnglish speaking Allergy contraindication topical anesthetic Participation/randomization study previous visit Currently pregnant lactate planning pregnancy within next 6 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pessary</keyword>
	<keyword>Pain</keyword>
	<keyword>EMLA</keyword>
	<keyword>lidocaine</keyword>
	<keyword>prilocaine</keyword>
</DOC>